Andrew Lawrence Taylor - 10 Jun 2026 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Jun 2026, 16:16:25 UTC
Prior SEC filing
29 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Taylor

Key filing fact

Andrew Lawrence Taylor filed Form 4 for Orchestra BioMed Holdings, Inc. (OBIO) on 12 Jun 2026.

Key facts

  • This page summarizes Andrew Lawrence Taylor's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Jun 2026, 16:16.

Change

  • Previous filing in this sequence was filed on 29 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001723889 Primary reporting owner

Taylor Andrew Lawrence

Relationship
Chief Financial Officer
Address
C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE
Signature
/s/ Andrew Taylor
Signature date
12 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OBIO transaction

Common Stock, par value $0.0001 per share

Tax liability

Transaction value
Shares
-36,352
Change %
-5.8%
Price
$4.02*
Shares after
593,065
Date
10 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .